ACADIA Pharmaceuticals Overview
- Founded
- 1993
- Status
- Public
- Employees
- 580
- Stock Symbol
- ACAD
- Investments
- 1
- Share Price
- $53.66
- (As of Friday Closing)
ACADIA Pharmaceuticals General Information
Description
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
- 3611 Valley Centre Drive
- Suite 300
- San Diego, CA 92130
- United States
+1 (858) 000-0000
ACADIA Pharmaceuticals Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $53.66 | $54.46 | $30.02 - $58.72 | $8.53B | 159M | 1M | -$1.71 |
ACADIA Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 5,902,541 | 5,915,630 | 2,109,129 | 3,373,207 |
| Revenue | 419,074 | 339,076 | 223,807 | 124,901 |
| EBITDA | (273,865) | (242,782) | (246,279) | (289,697) |
| Net Income | (267,860) | (235,259) | (245,192) | (289,403) |
| Total Assets | 795,664 | 783,183 | 540,202 | 384,506 |
| Total Debt | 49,200 | 9,795 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
ACADIA Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore ACADIA Pharmaceuticals‘s full profile, request access.
Request a free trialACADIA Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address
Pharmaceuticals
San Diego, CA
580
As of 2020
00000
000000&0
0000 000
ris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
0000000000000
Cambridge, MA
000
As of 0000
00.000
000000000
00.000
00000000
ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolo
000000000000000
Coral Gables, FL
00
As of 0000
000.00
0000
0000-00-00
00000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialACADIA Pharmaceuticals Competitors (46)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SAGE Therapeutics | Formerly VC-backed | Cambridge, MA | 000 | 00.000 | 000000000 | 00.000 |
| 00000000 000000000 | Formerly VC-backed | Coral Gables, FL | 00 | 000.00 | 00000000 | 000.00 |
| 00 0000000 | Formerly Accelerator/Incubator backed | Paris, France | 00 | 000.00 | 000000000 | 000.00 |
| 000000000 00000000 | Corporation | Pasadena, CA | 000 | 00.000 | 000000 - 000 | 00.000 |
| 0000000000000 0000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000 | 00000 |
ACADIA Pharmaceuticals Executive Team (19)
ACADIA Pharmaceuticals Board Members (13)
| Name | Representing | Role | Since |
|---|---|---|---|
| Daniel Soland | Self | Board Member | 000 0000 |
| Edmund Harrigan MD | Self | Board Member | 000 0000 |
| Julian Baker | Self | Board Member | 000 0000 |
| Laura Brege | ACADIA Pharmaceuticals | Board Member | 000 0000 |
| Stephen Biggar Ph.D | Self | Chairman & Board Member | 000 0000 |
ACADIA Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialACADIA Pharmaceuticals Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 | 24-Aug-2020 | 000000000000000000 | 000.00 | Biotechnology | 0000000 00000 00 |
ACADIA Pharmaceuticals Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000 | Biotechnology | Dallas, TX | 0000 |